Figure S10. Expression of ZEB1/ZEB2 and miR-429/miR-200b-3p in A549 cells treated with TGF-β1 in time-dependent manner. After being serum-starved for 24 h, A549 cells were exposed to 5 ng/ml TGF-β1 for the indicated times, and the expression of ZEB1/ZEB2 (A, B) and miR-429/miR-200b-3p (C, D) were determined by qRT-PCR analysis. (TIF 2073 kb
Figure S1. miR-200b is correlated with FSCN1 and inhibits cell cycle and proliferation (A) Correlati...
Figure S1. circFNDC3B inhibits proliferation of BC cells. a and b qRT-PCR analysis for circFNDC3B an...
Figure S1. Identification of circRNA 100146 and its expression in lung cancer tissues. Figure S2. Su...
Figure S4. CircPTK2 abolishes endogenous miR-429/miR-200b-3p-mediated repression of TIF1γ and inhibi...
Figure S5. miR-200b-3p promotes TGF-β-induced EMT and invasion in NSCLC cells. (A) After being serum...
Figure S6. CircPTK2 knockdown inhibits TIF1γ expression and promotes TGF-β-induced EMT and invasion ...
Table S4. Demographic and clinical characteristics of 73 NSCLC patients and relative expression of m...
Figure S9. miR-429/miR-200b-3p are upregulated in NSCLC tissues. (A, B) qRT-PCR analysis of miR-429/...
Table S1. Arraystar Human circRNA Array analysis of A549 cells treated with TGF-β1. Among 187 differ...
Table S2. Sequences for construction of luciferase reporter plasmids containing predicted miR-429 an...
Figure S3. miR-200b-3p inhibits TIF1γ expression by targeting 3’-UTR of TIF1γ transcript. (A) Schema...
Figure S1. Reduced TIF1γ is expressed in NSCLC tissues and associated with poor survival of NSCLC pa...
Table S3. Demographic and clinical characteristics of 73 NSCLC patients and relative expression of c...
Figure S2. The in silico prediction of the interaction between miR-429/miR-200b-3p and circPTK2 or T...
Figure S7. CircPTK2 overexpression attenuates NSCLC cell metastasis in vivo by the bioluminescent im...
Figure S1. miR-200b is correlated with FSCN1 and inhibits cell cycle and proliferation (A) Correlati...
Figure S1. circFNDC3B inhibits proliferation of BC cells. a and b qRT-PCR analysis for circFNDC3B an...
Figure S1. Identification of circRNA 100146 and its expression in lung cancer tissues. Figure S2. Su...
Figure S4. CircPTK2 abolishes endogenous miR-429/miR-200b-3p-mediated repression of TIF1γ and inhibi...
Figure S5. miR-200b-3p promotes TGF-β-induced EMT and invasion in NSCLC cells. (A) After being serum...
Figure S6. CircPTK2 knockdown inhibits TIF1γ expression and promotes TGF-β-induced EMT and invasion ...
Table S4. Demographic and clinical characteristics of 73 NSCLC patients and relative expression of m...
Figure S9. miR-429/miR-200b-3p are upregulated in NSCLC tissues. (A, B) qRT-PCR analysis of miR-429/...
Table S1. Arraystar Human circRNA Array analysis of A549 cells treated with TGF-β1. Among 187 differ...
Table S2. Sequences for construction of luciferase reporter plasmids containing predicted miR-429 an...
Figure S3. miR-200b-3p inhibits TIF1γ expression by targeting 3’-UTR of TIF1γ transcript. (A) Schema...
Figure S1. Reduced TIF1γ is expressed in NSCLC tissues and associated with poor survival of NSCLC pa...
Table S3. Demographic and clinical characteristics of 73 NSCLC patients and relative expression of c...
Figure S2. The in silico prediction of the interaction between miR-429/miR-200b-3p and circPTK2 or T...
Figure S7. CircPTK2 overexpression attenuates NSCLC cell metastasis in vivo by the bioluminescent im...
Figure S1. miR-200b is correlated with FSCN1 and inhibits cell cycle and proliferation (A) Correlati...
Figure S1. circFNDC3B inhibits proliferation of BC cells. a and b qRT-PCR analysis for circFNDC3B an...
Figure S1. Identification of circRNA 100146 and its expression in lung cancer tissues. Figure S2. Su...